Tartóssági inzulin készítmény a cukorbetegség kezelése
Tartalom
Schweiz Med Wschr —, Tayek, JA: Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation.
Am J Med Sci —, Hellman, B, Schlin, J, Taljedal, IB: Glibenclamide is exceptional among hypoglycaemic agents in accumulating progressively in beta-cell rich pancreatic islands.
Acta Endocrinol —, Matsuda, A, Kuzuya, T, Sugita.
Y, Kawashima, K: Plasma levels of glibenclamide in diabetic patients during its rutine clinical administration determined by a specific radioimmunossay. Horm Metabol Res —, Arzneimittelforschung —, Ann Clin Res 15 Suppl. Trinder, P: Determination of blood glucose using an oxydase-peroxydase system with a non-carcinogenic chromogen. J Clin Pathol —, Wilson, DH: Fully automated assay of glycohemoglobin with the IMx analyzer: Novel approaches for separation and detection.
Clin Chem —, Arzneimittelforschung Ann Clin Res 15, Suppl. Eur J Clin Pharmacol —, Farmakol Toksikol 40—43, The Diabetes Control and Complication Trial DCCT : The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med —, Med Welt —,